INSTINCT BIO TECHNICAL CO HOLDINGS INC.: CHARDAN CAPITAL MARKETS LLC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Chardan Capital Markets LLC disclosed a stake exceeding 5% in Instinct Bio Technical Co Holdings Inc. via a Schedule 13G filing with the SEC (accession 0001753926-26-002098). The filing signals the broker-dealer's position has crossed the threshold requiring passive-investor disclosure. The exact share count and percentage were not specified in the headline disclosure. Investors will watch for further 13G amendments or 13D filings to gauge whether Chardan's holding is passive or activist in nature.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Instinct Bio Technical Co Holdings Inc., Chardan Capital Markets LLC